| [1] |
Dalmau J, Graus F. Diagnostic criteria for autoimmune encephalitis: utility and pitfalls for antibody-negative disease[J]. Lancet Neurol, 2023, 22:529-540.doi: 10.1016/S1474-4422(23)00083-2.
|
| [2] |
Pandey R, Bakay M, Hakonarson H. SOCS-JAK-STAT inhibitors and SOCS mimetics as treatment options for autoimmune uveitis, psoriasis, lupus, and autoimmune encephalitis[J]. Front Immunol, 2023, 14:1271102-1271113. doi: 10.3389/fimmu.2023.1271102.
|
| [3] |
Cai J, Abudou H, Chen Y, et al. The effects of ECMO on neurological function recovery of critical patients: a double-edged sword[J]. Front Med (Lausanne), 2023, 10:1117214-1117225. doi: 10.3389/fmed.2023.1117214.
|
| [4] |
Dainichi T, Iwata M. Inflammatory loops in the epithelial-immune microenvironment of the skin and skin appendages in chronic inflammatory diseases[J]. Front Immunol,2023, 14:1274270-1274279. doi: 10.3389/fimmu.2023.1274270.
|
| [5] |
中华医学会神经病学分会神经感染性疾病与脑脊液细胞学学组. 中国自身免疫性脑炎诊治专家共识(2022年版). 中华神经科杂志, 2022, 55:931-949. doi:10.3760/cma.j.cn113694-20220219-00118.
|
| [6] |
王伟治. 神经病学[M]. 北京: 人民卫生出版社, 2006:609-610.
|
| [7] |
梁文娜, 郭守刚, 李立芳. 自身免疫性脑炎的预后因素[J]. 临床与病理杂志, 2019, 39:1016-1021.doi:10.3978/j.issn.2095-6959.2019.05.017.
|
| [8] |
Shang H, Shen X, Yu X, et al. B-cell targeted therapies in autoimmune encephalitis: mechanisms, clinical applications, and therapeutic potential[J]. Front Immunol,2024, 15:1368275-1368285. doi: 10.3389/fimmu.2024.1368275.
|
| [9] |
郑惠心, 孙嵩, 陈玉雯, 等. 病毒性脑炎患儿血清RANTES、Eotaxin表达水平及其临床意义[J]. 疑难病杂志, 2022, 21:461-465. doi:10.3969/j.issn.1671-6450.2022.05.004.
|
| [10] |
Reynolds L, Luo Z, Singh K. Diabetic complications and prospective immunotherapy[J]. Front Immunol, 2023, 14:1219598-1219616. doi: 10.3389/fimmu.2023.1219598.
|
| [11] |
季玮, 朱玥, 尧惠慈, 等. 白三烯C4及2型固有淋巴细胞在支气管肺发育不良中的变化及意义[J]. 基础医学与临床, 2023, 43:711-716. doi:10.16352/j.issn.1001-6325.2023.05.0711.
|
| [12] |
唐才环, 薛芳, 陈乙云, 等. 病毒性脑炎患儿脑脊液和血清中LTC4及UCH-L1变化及其临床意义[J]. 热带医学杂志, 2023, 23:1719-1723. doi:10.3969/j.issn.1672-3619.2023.12.014.
|